In line with the tumor-suppressive role acted by miR-890 in the present study, miR-890 was reported to inhibit proliferation and invasion and induced apoptosis in triple-negative breast cancer cells by targeting CD147 [47]; it was also demonstrated that LINC00662 promoted cell proliferation, migration and invasion of melanoma by sponging miR-890 to up-regulate ELK3 [48]. This evidence concerns the gene ELK3 and melanoma.